Ocean Biomedical receives Nasdaq non-compliance notice for late Q1 2024 10-Q filing

Ocean Biomedical, Inc.

Nasdaq notice received May 22, 2024 due to failure to file Form 10-Q for period ended March 31, 2024.
Company must submit a plan to regain compliance by June 14, 2024, and file delinquent 10-Q by October 14, 2024.
No immediate effect on listing or trading of OCEA common stock or OCEAW warrants, but further delays could impact.
Ocean Biomedical cites previously disclosed delays from its 2023 10-K as the cause.
Company intends to file the delinquent Form 10-Q as soon as practicable.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.